首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats
【2h】

Hypoxis hemerocallidea Significantly Reduced Hyperglycaemia and Hyperglycaemic-Induced Oxidative Stress in the Liver and Kidney Tissues of Streptozotocin-Induced Diabetic Male Wistar Rats

机译:Hypoxis hemerocallidea显着降低链脲佐菌素诱导的糖尿病雄性Wistar大鼠肝脏和肾脏组织中的高血糖和高血糖诱导的氧化应激

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Hypoxis hemerocallidea is a native plant that grows in the Southern African regions and is well known for its beneficial medicinal effects in the treatment of diabetes, cancer, and high blood pressure. Aim. This study evaluated the effects of Hypoxis hemerocallidea on oxidative stress biomarkers, hepatic injury, and other selected biomarkers in the liver and kidneys of healthy nondiabetic and streptozotocin- (STZ-) induced diabetic male Wistar rats. Materials and Methods. Rats were injected intraperitoneally with 50 mg/kg of STZ to induce diabetes. The plant extract-Hypoxis hemerocallidea (200 mg/kg or 800 mg/kg) aqueous solution was administered (daily) orally for 6 weeks. Antioxidant activities were analysed using a Multiskan Spectrum plate reader while other serum biomarkers were measured using the RANDOX chemistry analyser. Results. Both dosages (200 mg/kg and 800 mg/kg) of Hypoxis hemerocallidea significantly reduced the blood glucose levels in STZ-induced diabetic groups. Activities of liver enzymes were increased in the diabetic control and in the diabetic group treated with 800 mg/kg, whereas the 200 mg/kg dosage ameliorated hepatic injury. In the hepatic tissue, the oxygen radical absorbance capacity (ORAC), ferric reducing antioxidant power (FRAP), catalase, and total glutathione were reduced in the diabetic control group. However treatment with both doses improved the antioxidant status. The FRAP and the catalase activities in the kidney were elevated in the STZ-induced diabetic group treated with 800 mg/kg of the extract possibly due to compensatory responses. Conclusion. Hypoxis hemerocallidea demonstrated antihyperglycemic and antioxidant effects especially in the liver tissue.
机译:背景。 Hypoxis hemerocallidea是一种生长在南部非洲地区的本地植物,以其在治疗糖尿病,癌症和高血压方面的有益药物作用而闻名。目标。这项研究评估了Hypoxis hemerocallidea对健康的非糖尿病和链脲佐菌素(STZ-)诱导的糖尿病雄性Wistar大鼠肝脏和肾脏中氧化应激生物标志物,肝损伤和其他选定生物标志物的影响。材料和方法。给大鼠腹膜内注射50μg/ kg的STZ诱发糖尿病。每天(每天)口服植物提取物-Hypoxis hemerocallidea(200μg/ kg或800μg/ kg)水溶液,持续6周。使用Multiskan Spectrum读板仪分析抗氧化活性,同时使用RANDOX化学分析仪测量其他血清生物标志物。结果。 Hypoxis hemcallcallidea的两种剂量(200μmg/ kg和800μmg/ kg)均显着降低STZ诱导的糖尿病组的血糖水平。糖尿病对照组和800μg/ kg的糖尿病组肝酶活性增加,而200μg/ kg的剂量改善了肝损伤。在肝组织中,糖尿病对照组的氧自由基吸收能力(ORAC),铁还原抗氧化能力(FRAP),过氧化氢酶和总谷胱甘肽降低。然而,两种剂量的治疗均改善了抗氧化剂的状态。在STZ诱导的糖尿病组中,用800μmg/ kg提取物治疗的肾脏中FRAP和过氧化氢酶活性升高,可能是由于代偿性反应。结论。 Hypoxis hemerocallidea表现出降血糖和抗氧化作用,尤其是在肝脏组织中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号